Drug intelligence / Profile preview

ENX-201

Development stage
Preclinical
Lead developer
EnhanX Biopharm
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

ENX-201 (formerly 2B3-201) is a brain-targeted, glutathione-decorated PEGylated liposomal formulation of methylprednisolone developed by EnhanX Biopharm. The drug utilizes a proprietary delivery platform known as G-Technology, which employs glutathione-coated liposomes to facilitate the transport of methylprednisolone across the blood-brain barrier (BBB) via endogenous glutathione transporters. By enhancing CNS penetration and potentially reducing systemic exposure, ENX-201 is designed to treat neuroinflammatory conditions such as acute relapsing multiple sclerosis (MS) more effectively than standard corticosteroid therapy. It has been evaluated in Phase 1 clinical trials for safety, tolerability, and pharmacokinetics in patients with relapsing MS.

Other names
glutathione PEGylated liposomal methylprednisolone
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on ENX-201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENX-201.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call